The Glycomics Core provides services, instrumentation and expertise in glycomics to BIDMC research groups, affiliated and non-affiliated institutions and corporate companies.
The services proposed by the Glycomics Core includes:
- Glycan Microarrays
- Glycan analysis by Mass Spectrometry
- Distribution of specific reagents
The work is done on a fee-for-service basis.
The National Center for Functional Glycomics (NCFG) is an outgrowth of the high successful Consortium for Functional Glycomics (CFG) funded by the NIGMS/NIH from 2001 to 2014. The CFG generated two types of glycan microarrays that are available as a fee-for-service and approved by the Steering Committee of the CFG. These are the CFG Glycan Microarray version 5.2, and the Microbial Glycan Microarray (MGM) (also previously termed the Pathogen Array). Dr. Cummings is the Chair of the CFG, a world-wide consortium of more than 600 Participating Investigators whose research is funded in the area of glycobiology or related sciences.
The NCFG is devoted to understanding protein-glycan interactions and its major resources are developments of new glycan microarrays and other technologies to identify ligands recognized by glycan-binding proteins, antibodies, and microbes.
Beth Israel Deaconess Medical Center
Slosberg/Landay-Dana Building, 4th Floor, room SL-0417
330 Brookline Avenue
Boston, MA 02115